Aplastic Anemia

Transplantation for Bone Marrow Failure, AAMDSIF 2026 International Bone Marrow Failure Scientific Symposium

Thumbnail for video Watch Now

Topic(s)
Bone Marrow Transplant
Presenter(s)
Richard Childs, MD
Amy E. DeZern, MD, MHS
Neal Young, MD
Nicolaus Kroger, MD
The session was recorded at the AAMDSIF 2026 International Bone Marrow Failure Scientific Symposium, Co-Chairs Rick Childs, MD, and Amy DeZern, MD, MHS. Session topics included: Two options for patients are better than one: - Upfront alternative transplant for SAA - Amy DeZern…

Non-Transplant Therapies for Marrow Failure, AAMDSIF 2026 International Bone Marrow Failure Scientific Symposium

Thumbnail for video Watch Now

Presenter(s)
Carlos DeCastro, MD
Phil Scheinberg, MD
Regis Peffault de Latour, MD, PhD
Julian Sevilla, MD, PhD
Kasiani Myers, MD
Suneet Agarwal, MD, PhD
This session was presented at the AAMDSIF 2026 International Bone Marrow Failure Scientific Symposium; Co-Chairs Carlos DeCastro, MD, and Phil Scheinberg, MD, PhD. Session topics included: -Androgens, alemtuzumab, anti-cytokine therapies (anti-IL2R, anti-IFN gamma), daratumumab…

Clonality in Acquired Bone Marrow Failure, PNH, and VEXAS, AAMDSIF 2026 International Bone Marrow Failure Scientific Symposium

Thumbnail for video Watch Now

Topic(s)
Aplastic Anemia
Paroxysmal Nocturnal Hemoglobinuria (PNH)
Presenter(s)
Emma Groarke, MD, FRCPath
Yoshitaka Zaimoku, MD, PhD
Hiroki Mizumaki, MD
Martina Fiumara, PhD
Austin Kulasekararaj, MBBS, MD
Bhavisha Patel, MD
Thibault Comont, MD
This session, Clonality in Acquired Bone Marrow Failure, PNH, and VEXAS, was recorded at the AAMDSIF 2026 International Scientific Symposium; session Co-Chairs Emma Groarke, MD, and Yoshitaka Zaimoku, MD, PhD Session topics and speakers included: -Insights of PNH using single…

David Young, MD, PhD

Institution
NIH
Primary Disease Area of Focus
Aplastic Anemia
Paroxysmal Nocturnal Hemoglobinuria (PNH)
Pediatric
About

Dr. Young is a board-certified Pediatrician and Pediatric Hematologist and Oncologist who studies the genetics, molecular biology, and clinical management and treatment of bone marrow failure syndromes, myeloid malignancies, and other genetic disorders. He oversees clinical trials in aplastic anemia and Diamond-Blackfan anemia while also working with non-human primate models of disease and preclinical development. He also serves as the Medical Director for the RUNX1 Natural History Program of the National Human Genome Research Institute. Dr. Young received a B.Sc. from the University of Notre

Enrico Attardi, MD, PhD

Institution
University of Rome Tor Vergata
Primary Disease Area of Focus
Acute Myeloid Leukemia (AML)
Aplastic Anemia
Myelodysplastic Syndromes (MDS)
About

MD, PhD. My main scientific interests concern germline predisposition to bone marrow failures and myeloid neoplasms, particularly to myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML). I am also deeply intrigued by the intersection of inborn errors of immunity (IEIs) and hemopathies.

How I select hematopoietic cell donors in the era of posttransplant cyclophosphamide

Original Publication Date
Article Source
External Web Content

Abstract Selection of a hematopoietic progenitor cell donor for allogeneic hematopoietic cell transplantation (HCT) is essential for treatment planning; however, the parameters that define an “optimal” donor in the modern era are not well defined. Historically, donor-recipient…

Subscribe to Aplastic Anemia

Website Feedback

Please use this feedback form to report website issues only. For other issues concerning patients and families, please email help@aamds.org or use the Patient and Family Helpline here.